BMRNBioMarin Pharmaceutical Inc.

$65.62

Who owns BMRN

538 institutions reported holding BMRN for 2026Q1, together 93% of the company, more than the 524 a quarter earlier.

538

Institutions reporting a position · as of 2026Q1 · up from 524 the quarter before

Shares held by institutions
183.3M

Shares held by institutions · 93% of the company · long US equity positions only, as reported on Form 13F

Reported value
$10.4B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
38%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
52
New positions
82
Positions exited
74
Added to
193
Reduced
149
Top 10 holdersof the company
51%
Institutional ownership by quarter, 2013Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1538183.3M$10.4B
2025Q4524188.0M$11.2B
2025Q3568179.3M$9.71B
2025Q2570184.3M$10.1B
2025Q1575186.1M$13.1B
2024Q4540183.2M$12.0B
2024Q3546180.4M$12.7B
2024Q2552184.7M$15.2B
2024Q1550186.2M$16.3B
2023Q4540185.2M$17.9B
2023Q3511180.8M$16.0B
2023Q2553178.1M$15.4B
2023Q1546177.0M$17.2B
2022Q4572181.6M$18.8B
2022Q3543181.4M$15.4B
2022Q2533178.2M$14.8B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.19.8M10%$1.12B
VANGUARD GROUP INC18.5M9.3%$1.04B
Dodge & Cox14.6M7.4%$823M
PRIMECAP MANAGEMENT CO/CA/14.2M7.2%$802M
AQR CAPITAL MANAGEMENT LLC7.7M3.9%$429M
STATE STREET CORP7.3M3.7%$412M
VIKING GLOBAL INVESTORS LP7.1M3.6%$399M
CITADEL ADVISORS LLC4.5M2.3%$255M
GEODE CAPITAL MANAGEMENT LLC3.8M1.9%$216M
DIMENSIONAL FUND ADVISORS LP3.8M1.9%$215M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…